Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZRANB2 antisense RNA 1 (ZRANB2-AS1) is a long non-coding RNA gene located on chromosome 1 that is transcribed as an antisense RNA in relation to the ZRANB2 gene[3][5]. It does not encode a protein but rather functions at the RNA level, regulating cellular processes such as cell proliferation, apoptosis, and migration[3]. ZRANB2-AS1 is believed to interact with proteins, potentially including the splicing factor ZRANB2, and regulate gene expression through mechanisms such as acting as a microRNA sponge[3]. Dysregulation of ZRANB2-AS1 has been linked to cancer, but its precise mechanisms remain poorly understood and are under ongoing investigation; it is not currently known to be a direct therapeutic target or have interacting drugs in clinical use[3][5]. ZRANB2-AS1 should not be confused with the protein-coding gene ZRANB2, which is a zinc finger splicing factor involved in RNA splicing and implicated in cancer drug resistance[4][7]. ZRANB2-AS1 itself is a regulatory long non-coding RNA, not an enzyme, receptor, transporter, or direct drug target.
Regulation of gene expression, possibly via microRNA sponge activity and protein interactions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZRANB2 antisense RNA 1 (ZRANB2-AS1).